Reading the annual reports…

First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.

Mount Logan Capital Inc. (MLCI) financial health, profit and balance sheet · Scorvest

MLCI · Nasdaq · United States · Investment Advice

Mount Logan Capital Inc.

New York, NY · Fiscal year ends in December · Figures in USD

+ Add to watchlist Compare

In shortMount Logan Capital Inc. is loss-making.

Financial health

Weak

Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.

How is this score calculated? →

Profitability0

Operating marginShare of each sale left after running the business, before interest and tax.	–	n/a
Net marginShare of each sale left as profit after every cost, interest and tax.	-113.6%	0/100
Return on equityProfit earned on the money shareholders put in. Above 15% is strong.	-62.4%	0/100

Weight in the score: 25%

Balance sheet21
Equity / assets 5.7% 21/100
Weight in the score: 25%

Equity / assets	5.7%	21/100

Cash generation–

Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt.	-41.4%	n/a
Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy.	–	n/a
Years with positive free cash flow (last 5)	0 of 2	n/a

Weight in the score: 20%

Stability50
Profitable years (last 5) 0 of 2 0/100
Years of revenue decline (last 5) 0 of 1 100/100
Revenue growth volatility – n/a
Operating margin volatility – n/a
Weight in the score: 20%
Growth–
Revenue growth, 3-year average – n/a
EPS growth, 3-year average – n/a
Weight in the score: 10%

Profitable years (last 5)	0 of 2	0/100
Years of revenue decline (last 5)	0 of 1	100/100
Revenue growth volatility	–	n/a
Operating margin volatility	–	n/a

Revenue growth, 3-year average	–	n/a
EPS growth, 3-year average	–	n/a

Fiscal year 2025 · change vs prior year

Revenue: $53.6M; ▲ 7.6%
Net income: −$60.8M; ▼ 485.8%
Total assets: $1.6B; ▲ 2.5%
Operating margin: –; –
Cash & investments: $0; –
Total debt: $76.3M; –
Diluted EPS: −$7.08; ▼ 316.5%
Return on equity: −62.4%; –

Trends

Annual figures as reported. Hover a bar or point for the exact value.

Revenue and net income

RevenueNet income

Margins

OperatingNet

Cash versus debt

Statements

The last 2 fiscal years from the company's annual reports.

USD millions; negative values in parentheses.

Fiscal year	FY24	FY25
Revenue	50	54
Interest expense	7	7.8
Pre-tax income	(9.8)	(58)
Net income	(10)	(61)
Diluted EPS	−$1.70	−$7.08
Diluted shares (millions)	6.1	8.6

🔒 Export to Excel · Investor plan

Risk checks

Altman Z'' score

Not computed: the model does not apply to banks and insurers.

Piotroski F-score

2/9

Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.

Positive net income: failed
Positive operating cash flow: failed
Return on assets improved: failed
Cash flow exceeds net income: passed
Long-term debt ratio fell: failed
Current ratio improved: not available
No share dilution: failed
Gross margin improved: not available
Asset turnover improved: passed

Sources

10-QPeriod ending Jun 30, 2026Filed Aug 11, 2026Open the report ↗
10-QPeriod ending Mar 31, 2026Filed May 14, 2026Open the report ↗
10-KPeriod ending Dec 31, 2025Filed Mar 19, 2026Open the report ↗
10-QPeriod ending Sep 30, 2025Filed Nov 13, 2025Open the report ↗
10-QPeriod ending Jun 30, 2025Filed Aug 25, 2025Open the report ↗

All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works

Latest annual report: Jun 30, 2026 · Data updated Aug 11, 2026